1. Home
  2. SQNS vs CUE Comparison

SQNS vs CUE Comparison

Compare SQNS & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • CUE
  • Stock Information
  • Founded
  • SQNS 2003
  • CUE 2014
  • Country
  • SQNS France
  • CUE United States
  • Employees
  • SQNS N/A
  • CUE N/A
  • Industry
  • SQNS Semiconductors
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • CUE Health Care
  • Exchange
  • SQNS Nasdaq
  • CUE Nasdaq
  • Market Cap
  • SQNS 85.7M
  • CUE 91.9M
  • IPO Year
  • SQNS 2011
  • CUE 2018
  • Fundamental
  • Price
  • SQNS $3.11
  • CUE $1.26
  • Analyst Decision
  • SQNS Strong Buy
  • CUE Strong Buy
  • Analyst Count
  • SQNS 1
  • CUE 5
  • Target Price
  • SQNS $7.50
  • CUE $5.00
  • AVG Volume (30 Days)
  • SQNS 107.6K
  • CUE 285.1K
  • Earning Date
  • SQNS 02-11-2025
  • CUE 03-10-2025
  • Dividend Yield
  • SQNS N/A
  • CUE N/A
  • EPS Growth
  • SQNS N/A
  • CUE N/A
  • EPS
  • SQNS 1.65
  • CUE N/A
  • Revenue
  • SQNS $30,555,000.00
  • CUE $9,532,000.00
  • Revenue This Year
  • SQNS $10.14
  • CUE $73.11
  • Revenue Next Year
  • SQNS $8.54
  • CUE $11.02
  • P/E Ratio
  • SQNS $1.90
  • CUE N/A
  • Revenue Growth
  • SQNS N/A
  • CUE 149.53
  • 52 Week Low
  • SQNS $0.85
  • CUE $0.45
  • 52 Week High
  • SQNS $7.43
  • CUE $2.58
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 50.30
  • CUE 49.50
  • Support Level
  • SQNS $3.00
  • CUE $1.27
  • Resistance Level
  • SQNS $3.64
  • CUE $1.50
  • Average True Range (ATR)
  • SQNS 0.22
  • CUE 0.12
  • MACD
  • SQNS -0.01
  • CUE -0.01
  • Stochastic Oscillator
  • SQNS 34.78
  • CUE 53.73

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Share on Social Networks: